Search results
Results from the WOW.Com Content Network
The Dengvaxia controversy (locally [dɛŋˈvakʃa]) occurred in the Philippines when the dengue vaccine Dengvaxia was found to increase the risk of disease severity for some people who had received it. [1] [2] A vaccination program run by the Philippine Department of Health (DOH) administered Sanofi Pasteur's Dengvaxia to schoolchildren. [3]
Dengue vaccine is a vaccine used to prevent dengue fever in humans. [9] Development of dengue vaccines began in the 1920s but was hindered by the need to create immunity against all four dengue serotypes. [10] As of 2023, there are two commercially available vaccines, sold under the brand names Dengvaxia and Qdenga. [11] [12]
The Philippines is considering re-introducing a dengue vaccine whose use it halted because of links to the deaths of several children, as authorities battle to contain a dengue outbreak that has ...
The World Health Organization has prequalified a new dengue vaccine recommended for use in children in areas where mosquito transmission to humans is high.
In May 2024, TAK-003 became the second dengue vaccine to be prequalified by the World Health Organization (WHO). [51] This live-attenuated vaccine, developed by Takeda is similar to the Dengvaxia vaccine in the fact that it contains a weakened version of the four variants of dengue virus. The difference between the two vaccines is the TAK-003 ...
A new vaccine candidate was more than 83 percent effective at protecting against hospitalizations over a three-year clinical trial. Dengue virus is a mosquito-borne disease that can cause severe ...
The Department of Health (DOH) of the Philippines declared a measles outbreak in Metro Manila due to a 550% increase in the number of patients from January 1 to February 6, 2019, compared to figures of the equivalent period from 2018. [1] Outbreaks were also officially declared in Central Luzon, Calabarzon, Western Visayas, Central Visayas.
The U.S. Defense Department admitted that it spread propaganda in the Philippines aimed at disparaging China’s Sinovac vaccine during the COVID-19 pandemic, according to a June 25 document cited ...